Australian men's experiences during a microbicide male tolerance study
- 10 December 2008
- journal article
- research article
- Published by Taylor & Francis in AIDS Care
- Vol. 21 (1) , 125-130
Abstract
Microbicides currently in development have the potential to provide new options for the prevention of sexually transmitted infections if proven safe and efficacious. We examined the experiences of healthy male volunteers in a male tolerance study in Victoria, Australia in relation to trial participation and product use. Men (N=36) enrolled in a seven-day, phase 1 clinical safety trial of SPL7013 were interviewed pre and post-use of the gel using a semi-structured interview guide. Interviews were digitally recorded and transcribed verbatim, and transcripts were analysed using a framework approach. All but one man completed the trial. The median age was 34 years (range 22–67 years). Most men had little pre-study knowledge of microbicides and almost all participated for altruistic or personal reasons. Men expressed few concerns about product safety during the trial and indicated trust in the information received through the consent process and from study staff. Three men were non-adherent to the request to be abstinent and an additional two did not refrain from masturbation. Most were positive about the gel, although they described it as “sticky” and found that it stuck to clothes, bed sheets and pubic hair. The type of applicator used was unfamiliar to the men, and some found it “clinical” in appearance. Men are willing to participate in male tolerance studies, often for altruistic reasons. However, counseling about ways to maintain abstinence and further research to inform anticipatory guidance regarding the “sticky” quality of gels, may be important.Keywords
This publication has 21 references indexed in Scilit:
- A Randomized Controlled Trial of the Safety of Candidate Microbicide SPL7013 Gel When Applied to the PenisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050)AIDS Care, 2007
- Assessing Microbicide Acceptability: A Comprehensive and Integrated ApproachAIDS and Behavior, 2007
- The Future of HIV Prevention: Prospects for an Effective Anti-HIV MicrobicideInfectious Disease Clinics of North America, 2007
- Preparing for microbicide trials in Rwanda: Focus group discussions with Rwandan women and menCulture, Health & Sexuality, 2006
- Examining the context of microbicide acceptability among married women and men in IndiaCulture, Health & Sexuality, 2006
- ErratumJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Women's Willingness to Participate in Microbicide Trials in Northern ThailandJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Factors Affecting African-American Participation in AIDS ResearchJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Factors Affecting African-American Participation in AIDS ResearchJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000